Global Eye Drop Markets Report 2022: Market to Reach $19.75 Billion by 2027 from $13.53 Billion in 2021
09 Jun 2022
Acquisition
DUBLIN, June 9, 2022 /PRNewswire/ -- The "Global Eye Drop Market By Type (Prescription v/s Over-the-Counter), By Drug Class (Anti-allergy, Anti-glaucoma, Anti-inflammatory, Anti-VEGF, and Others), By Disease Indication, By Distribution Channel, By Region, Competition Forecast and Opportunities, 2027" report has been added to
ResearchAndMarkets.com's offering.
The Global Eye Drop Market was valued at USD13530 million in 2021 and is anticipated to grow with a CAGR of 6.46% during the forecast period to achieve a market value of USD19758 million by 2027.
The market is anticipated to grow on account of increasing instances of eye infection in the population. Higher prevalence of eye diseases like eye dryness, redness, itching in the eyes, conjunctivitis, soreness, glaucoma, etc. further drive the growth of the Global Eye Drop Market in the upcoming five years.
Excessive screen time and penetration of smart phones, laptops, television, and electronics further supports the growth of the Global Eye Drop Market in the next five years. The governments around the world are actively investing in the healthcare industry and increasing the production of the pharmaceuticals and therapeutics products in the recent years.
Growing imports & exports of the pharmaceutical & therapeutics products like eye drops further aid the growth of the Global Eye Drop Market in the future five years. Also, the consumers in the country have been spending over healthcare services to attain excellent patient care. Rising disposable income of the population also sustains the market growth.
Technological advancement in product manufacturing, expanding logistics sector with easy distribution of the products further aids the growth of the Global Eye Drop Market in the forecast period.
Based on type, the market is further differentiated into prescription and over the counter. Prescription type eye drops are anticipated to hold
the largest revenue shares of the market and dominate the market segment in the upcoming five years on account of increasing instances of eye diseases.
Increasing instances of diabetes and thus higher risks of catching eye diseases, vision impairment, also aids to the growth of the segment. Over the counter eye drops are expected to achieve the fastest growth owing to increasing tendency of the consumers to self-medicate their conditions of eye burning sensations and redness, etc.
Increasing common eye itchiness and dryness due to prolonged screen times also aid to the growth of the sub-segment along with the growth of the Global Eye Drop Market in the future five years.
Objective of the Study:
To analyze the historical growth in the market size of the Global Eye Drop Market from 2017 to 2021.
To estimate and forecast the market size of the Global Eye Drop Market from 2022E to 2027F and growth rate until 2027F.
To classify and forecast the Global Eye Drop Market based on type, drug class, disease indication, distribution channel, competitional landscape, and regional distribution.
To identify dominant region or segment in the Global Eye Drop Market.
To identify drivers and challenges for the Global Eye Drop Market.
To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global Eye Drop Market.
To identify and analyze the profile of leading players operating in the Global Eye Drop Market.
To identify key sustainable strategies adopted by the market players in the Global Eye Drop Market.
Major market players in the Global Eye Drop Market
Years considered for this report:
Historical Years: 2017- 2020
Base Year: 2021
Estimated Year: 2022E
Forecast Period: 2023F - 2027F
Eye Drop Market, By Type:
Prescription
Over-The-Counter
Eye Drop Market, By Drug Class:
Anti-allergy
Anti-glaucoma
Anti-inflammatory
Anti-VEGF
Others
Eye Drop Market, By Disease Indication:
Eye Drop Market, By Distribution Channel:
Hospitals Pharmacy
Eye Drop Market, By Region:
North America
United States
Canada
Mexico
Europe
Russia Federation
United Kingdom
Germany
France
Spain
Italy
Asia-Pacific
China
India
Japan
Australia
South Korea
Indonesia
South America
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
South Africa
Saudi Arabia
UAE
Kuwait
For more information about this report visit https://www.researchandmarkets.com/r/23szuc
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.